Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Analytical and Bioanalytical Chemistry|April 14, 2022
Use of hyphenated analytical techniques to identify the bioactive constituents of Gunnera perpensa L., a South African medicinal plant, which potently inhibit SARS-CoV-2 spike glycoprotein-host ACE2 bindingLuke Invernizzi, Phanankosi Moyo, Joel Cassel, et al.
American Journal of Medical Genetics. Part A|May 12, 2005
EMX2-independent familial schizencephaly: clinical and genetic analysesIan Tietjen, Füsun Erdogan, Sophie Currier, et al.
Viruses|June 30, 2018
Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural ProductsKhumoekae Richard, David E Williams, E Dilip de Silva, et al.
Marine Drugs|January 10, 2019
Capillasterin A, a Novel Pyrano[2,3-f]chromene from the Australian Crinoid <i>Capillaster multiradiatus</i>Kah Yean Lum, Anthony R Carroll, Merrick G Ekins, et al.
Medicinal Chemistry Research : an International Journal for Rapid Communications on Design and Mechanisms of Action of Biologically Active Agents|April 22, 2024
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interactionDonatus B Eni, Joel Cassel, Cyril T Namba-Nzanguim, et al.
Bioorganic & Medicinal Chemistry Letters|February 29, 2024
Synthesis, SARS-CoV-2 main protease inhibition, molecular docking and in silico ADME studies of furanochromene-quinoline hydrazone derivativesBlake M Shellenberger, Olivia N Basile, Joel Cassel, et al.
Journal of Medicinal Chemistry|May 6, 2014
Aminoadamantanes with persistent in vitro efficacy against H1N1 (2009) influenza AAntonios Kolocouris, Christina Tzitzoglaki, F Brent Johnson, et al.
Molecular Pharmacology|May 20, 2016
Mechanisms of Action of Novel Influenza A/M2 Viroporin Inhibitors Derived from Hexamethylene AmiloridePouria H Jalily, Jodene Eldstrom, Scott C Miller, et al.
American Journal of Medical Genetics. Part A|May 17, 2007
Comprehensive EMX2 genotyping of a large schizencephaly case seriesIan Tietjen, Adria Bodell, Kira Apse, et al.
Chemical Biology & Drug Design|February 18, 2026
Fragment-Based Design of Pseudo-Natural Products, Synthesis, and Evaluation of Their HIV-1 Latency-Reversing PropertiesSolange A Tanyi, Donatus B Eni, Mohamed Abdelsalam, et al.
Pageof 6